Replimune shares plummet as skin cancer therapy fails mid-stage study – Times of India

Replimune Group said on Tuesday its experimental combination therapy to treat a common form of skin…

RBI likely to hold rates as inflation persists – Times of India

MUMBAI: India’s central bank will likely keep its key interest rate unchanged Friday, maintaining its focus…

Eyes on liquidity: RBI may not reverse CRR move soon – Times of India

MUMBAI: The banking system may still face liquidity pressure next week because many believe that RBI…